An investigation of the relationship between new fasting hormone asprosin, obesity and acute–chronic exercise: current systematic review

References

• Acara, A.C., and Guler, A., 2019. Investigation of the relationship between asprosin levels and metabolic parameters observed in clinical follow-up in patients with Type 2 Diabetes. Journal of basic and clinical health sciences, 3 (3), 128–134.
   Web of Science ®Google Scholar
• Ahima, R.S., 2006. Adipose tissue as an endocrine organ. Obesity, 14 (8), 242S–2249.
   PubMedGoogle Scholar
• Ahima, R.S., and Flier, J.S., 2000. Adipose tissue as an endocrine organ. Trends in endocrinology and metabolism: TEM, 11 (8), 327–332.
   PubMed Web of Science ®Google Scholar
• Alan, M., et al., 2019. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecological endocrinology: The official journal of the International Society of Gynecological Endocrinology, 35 (3), 220–223.
   PubMed Web of Science ®Google Scholar
• Balistreri, C.R., Caruso, C., and Candore, G., 2010. The role of adipose tissue and adipokines in obesity-related ınflammatory diseases. Mediators of inflammation, 2010, 802078.
   PubMed Web of Science ®Google Scholar
• Beutler, L.R., and Knight, Z.A., 2018. A spotlight on appetite. Neuron, 97 (4), 739–741.
   PubMed Web of Science ®Google Scholar
• Blüher, M., 2019. Adipokine & klinische Bedeutung. Adipositas-ursachen, folgeerkrankungen, therapie, 13 (1), 6–13.
   Google Scholar
• Blundell, J.E., et al., 2015. Appetite control and energy balance: impact of exercise. Obesity reviews, 16, 67–76.
   PubMed Web of Science ®Google Scholar
• Ceylan, H. I., Saygin, O., and Ozel Turkcu, U., 2020. Obezite, aerobik egzersiz ve sirkadiyen ritim iliskisi: asprosin, spexin, lipocalin-2 ve insulin hormonu uzerine yapilan bir arastirma. 3rd ed. Ankara: Gece Kitapligi.
   Google Scholar
• Chang, C.L., et al., 2019. The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients. Scientific reports, 9 (1), 1–11.
   PubMedGoogle Scholar
• Choe, S.S., et al., 2016. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Frontiers in endocrinology, 7, 30.
   PubMed Web of Science ®Google Scholar
• Chopra, A., and Moore, D. D., 2019. Methods for stimulation of appetite and increase in weight by administration of asprosin. U.S. Patent Application, 10372127, 25 June.
   Google Scholar
• Chouchani, E.T., and Kajimura, S., 2019. Metabolic adaptation and maladaptation in adipose tissue. Nature metabolism, 1 (2), 189–200.
   PubMedGoogle Scholar
• Coelho, M., Oliveira, T., and Fernandes, R., 2013. Biochemistry of adipose tissue: an endocrine organ. Archives of medical science: AMS, 9 (2), 191–200.
   PubMed Web of Science ®Google Scholar
• De Oliveira Leal, V., and Mafra, D., 2013. Adipokines in obesity. Clinica chimica acta; international journal of clinical chemistry, 419, 87–94.
   PubMed Web of Science ®Google Scholar
• Derosa, G., et al., 2020. Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markers in the progression of diabetes in obese patients (The resistin trial). Cytokine, 127, 154947.
   PubMed Web of Science ®Google Scholar
• Douglas, J.A., et al., 2017. Acute effects of exercise on appetite, ad libitum energy intake and appetite-regulatory hormones in lean and overweight/obese men and women. International journal of obesity, 41 (12), 1737–1744.
   Web of Science ®Google Scholar
• Duerrschmid, C., et al., 2017. Asprosin is a centrally acting orexigenic hormone. Nature medicine, 23 (12), 1444–1453.
   PubMed Web of Science ®Google Scholar
• Dulloo, A. G., 2010. Energy balance and body weight homeostasis. In: P.G. Kopelman, I.D. Caterson and W.H. Dietz, eds. Clinical obesity in adults and children. USA: John Wiley & Sons, 65–82.
   Google Scholar
• Edrees, H.M., and Morgan, E.N., 2018. Asprosin: a risk factor for obesity and metabolic disturbance. International journal of current research, 10 (9), 73319–73323.
   Google Scholar
• El Kattaw, Y.H.A., and Ashour, W.M., 2019. Anti-asprosin: a potential protective role against the progression of diabetic nephropathy in type 2 diabetic rats. American journal of biomedical sciences, 11 (3), 183–199.
   Google Scholar
• Elnagar, A., et al., 2018. Asprosin: a novel biomarker of type 2 diabetes mellitus. Veterinary medicine in-between health & economy, 55 (20), 333–347.
   Google Scholar
• Galic, S., Oakhill, J.S., and Steinberg, G.R., 2010. Adipose tissue as an endocrine organ. Molecular and cellular endocrinology, 316 (2), 129–139.
   PubMed Web of Science ®Google Scholar
• Goltz, F.R., et al., 2018. Interindividual responses of appetite to acute exercise: a replicated crossover study. Medicine & science in sports & exercise, 50 (4), 758–768.
   PubMed Web of Science ®Google Scholar
• Greenhill, C., 2016. Liver: Asprosin – new hormone involved in hepatic glucose release. Nature reviews. Endocrinology, 12 (6), 312.
   PubMedGoogle Scholar
• Groener, J.B., et al., 2019. Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes. PLoS One, 14 (9), e0222771.
   PubMed Web of Science ®Google Scholar
• Hazell, T.J., et al., 2016. Effects of exercise intensity on plasma concentrations of appetite-regulating hormones: potential mechanisms. Appetite, 98, 80–88.
   PubMed Web of Science ®Google Scholar
• Hellstrom, P.M., et al., 2004. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. British journal of nutrition, 92 (1), 47–57.
   Google Scholar
• Holmstrup, M.E., et al., 2013. Satiety, but not total PYY, is increased with continuous and intermittent exercise. Obesity, 21 (10), 2014–2020.
   PubMed Web of Science ®Google Scholar
• Hopkins, M., et al., 2006. The regulation of food intake in humans. San Francisco: Endotext.
   Google Scholar
• Itoh, M., et al., 2011. Adipose tissue remodeling as homeostatic inflammation. International journal of inflammation, 2011, 720926.
   PubMedGoogle Scholar
• Kahn, C.R., Wang, G., and Lee, K.Y., 2019. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. The Journal of clinical investigation, 129 (10), 3990–4000.
   PubMed Web of Science ®Google Scholar
• Kajimura, S., 2017. Adipose tissue in 2016: Advances in the understanding of adipose tissue biology. Nature reviews. Endocrinology, 13 (2), 69–70.
   PubMed Web of Science ®Google Scholar
• Katch, V. L., Mcardle, W. D., and Katch, F. I., 2011. Essentials of exercise physiology. Philadelphia: Offset Printing.
   Google Scholar
• Kelly, T., et al., 2008. Global burden of obesity in 2005 and projections to 2030. International journal of obesity (2005), 32 (9), 1431–1437.
   PubMed Web of Science ®Google Scholar
• Khalaj, S., and Mirzaei, B., 2020. Does an acute bout of high intensity interval exercise suppress appetite in obese women? Pedagogy of physical culture and sports, 24 (4), 181–188.
   Google Scholar
• King, J.A., et al., 2010. Influence of prolonged treadmill running on appetite, energy intake and circulating concentrations of acylated ghrelin. Appetite, 54 (3), 492–498.,
   PubMed Web of Science ®Google Scholar
• Ko, J.R., et al., 2019. Aerobic exercise training decreases hepatic asprosin in diabetic rat. Journal of clinical medicine, 8 (5), 666.
   Web of Science ®Google Scholar
• Lee, T., et al., 2019. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Molecular and cellular endocrinology, 486, 96–104.
   PubMed Web of Science ®Google Scholar
• Li, E., et al., 2019. OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell metabolism, 30 (2), 319–328.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2018. Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators of inflammation, 2018, 1–18.
   Web of Science ®Google Scholar
• Liberati, A., et al., 2009. The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS medicine, 6 (7), e1000100–94.
   PubMed Web of Science ®Google Scholar
• Linoby, A., et al., 2020. Acute moderate and high-intensity endurance exercise suppresses ad-libitum energy intake in obese males. Pertanika journal of science & technology, 28 (1), 279–292.
   Web of Science ®Google Scholar
• Long, W., et al., 2019. Decreased circulating levels of asprosin in obese children. Hormone research in paediatrics, 91 (4), 271–277.
   PubMed Web of Science ®Google Scholar
• Luo, L., and Liu, M., 2016. Adipose tissue in control of metabolism. Journal of endocrinology, 231 (3), R77–99.
   PubMed Web of Science ®Google Scholar
• Martins, C., Morgan, L., and Truby, H., 2008. A review of the effects of exercise on appetite regulation: an obesity perspective. International journal of obesity (2005), 32 (9), 1337–1347.
   PubMed Web of Science ®Google Scholar
• Matos, V., et al., 2018. Acute effects of high-intensity interval and moderate-intensity continuous exercise on glp-1, appetite and energy intake in obese men: a crossover trial. Nutrients, 10 (7), 889.
   Web of Science ®Google Scholar
• McCafferty, B.J., Hill, J.O., and Gunn, A.J., 2020. Obesity: scope, lifestyle interventions, and medical management. Techniques in vascular and interventional radiology, 23 (1), 100653.
   PubMed Web of Science ®Google Scholar
• Miller, G.D., 2019. Appetite regulation: hormones, peptides, and neurotransmitters and their role in obesity. American journal of lifestyle medicine, 13 (6), 586–601.
   PubMed Web of Science ®Google Scholar
• Nakhaei, H., Mogharnasi, M., and Fanaei, H., 2019. Effect of swimming training on levels of asprosin, lipid profile, glucose and insulin resistance in rats with metabolic syndrome. Obesity medicine, 15, 100111–100111.
   Google Scholar
• Oussaada, S.M., et al., 2019. The pathogenesis of obesity. Metabolism: clinical and experimental, 92, 26–36.
   PubMed Web of Science ®Google Scholar
• Romero, C., et al., 2016. Asprosin, a fasting-induced glucogenic protein hormone. Cell, 165 (3), 566–579.
   PubMed Web of Science ®Google Scholar
• Scheja, L., and Heeren, J., 2019. The endocrine function of adipose tissues in health and cardiometabolic disease. Nature reviews. Endocrinology, 15 (9), 507–524.
   PubMed Web of Science ®Google Scholar
• Schumann, U., et al., 2017. Asprosin, a newly identified fasting-induced hormone is not elevated in obesity and is insensitive to acute exercise. Medicine & science in sports & exercise, 49 (5), 1023.
   Web of Science ®Google Scholar
• Seo, D.Y., et al., 2020. Exercise decreases hepatic asprosin in stz-induced diabetic rats. Metabolism, 104, 154076.
   Web of Science ®Google Scholar
• Stensel, D., 2010. Exercise, appetite and appetite-regulating hormones: implications for food intake and weight control. Annals of nutrition and metabolism, 57 (s2), 36–42.
   PubMedGoogle Scholar
• Sunnetci, S.E., and Hatipoglu, H.U., 2020. Increased serum circulating asprosin levels in children with obesity. Pediatrics international: official journal of the Japan Pediatric Society. [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/32003085/ [Accessed 21 March 2020]
   Google Scholar
• Suzuki, K., et al., 2010. The role of gut hormones and the hypothalamus in appetite regulation. Endocrine journal, 57 (5), 359–372.
   PubMed Web of Science ®Google Scholar
• Ueda, S.Y., et al., 2018. Effects of walking in water on gut hormone concentrations and appetite: comparison with walking on land. Endocrine connections, 7 (1), 97–106.
   PubMed Web of Science ®Google Scholar
• Ugur, K., and Aydin, S., 2019. Saliva and blood asprosin hormone concentration associated with obesity. International journal of endocrinology, 2019, 2521096, 1–8..
   Web of Science ®Google Scholar
• Ugur, K., Yardim, M., and Aydin, S., 2018. Is asprosin, a real actor of diabetes etiopathology. Journal of molecular endocrinology, 3 (2), 111.
   Google Scholar
• Van den Beukel, J. C., and Grefhorst, A., 2014. Interactions between the gut, the brain and brown adipose tissue function. In: P.J.D. Delhanty and A.J van Der Lely, eds. How gut and brain control metabolism. Switzerland: Karger Publishers, 107–122.
   Google Scholar
• Wallis, G. A., et al., 2020. Energy metabolism. In: S.A. Lanham-New, ed. Introduction to human nutrition. UK: John Wiley and Sons, 113–130.
   Google Scholar
• Wang, C.Y., et al., 2019a. Serum asprosin levels and bariatric surgery outcomes in obese adults. International journal of obesity, 43 (5), 1019–1025.
   Web of Science ®Google Scholar
• Wang, M., et al., 2019b. Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity. Annals of nutrition & metabolism, 75 (4), 205–212.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2018. Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators of inflammation, 2018, 1–7.
   Web of Science ®Google Scholar
• Wiecek, M., et al., 2018. Acute anaerobic exercise affects the secretion of asprosin, irisin and other cytokines-a comparison between sexes. Frontiers in physiology, 9, 1782..
   PubMed Web of Science ®Google Scholar
• Wilson, L.F., et al., 2019. The impact of changing the prevalence of overweight/obesity and physical inactivity in Australia: an estimate of the proportion of potentially avoidable cancers 2013–2037. International journal of cancer, 144 (9), 2088–2098.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2018. Obesity and overweight [online]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight [Accessed 11 February 2019].
   Google Scholar
• Yuan, M., et al., 2020. Asprosin: a novel player in metabolic diseases. Frontiers in endocrinology, 11, 64.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2019a. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clinica chimica acta, 489, 183–188.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2019b. Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. Journal of diabetes investigation, 11 (2), 349–355.
   PubMed Web of Science ®Google Scholar